News

To Go Brands’ product line includes nutraceutical powder mixes, supplements and chews, which contain 100% natural antioxidant-rich drink mixes with organic ingredients, designed for use in home and

The alliance will offer integrated services and technologies across the entire clinical trial material supply chain spectrum to support all supply aspects in clinical development programs. Catalent clinical

The company has received permission to market the current batch of ChiRhoStim till its new manufacturing site becomes operational by the beginning of 2013. ChiRhoStim facilitates cannulation during

The FDA-approved trial will examine the safety and efficacy of ORMD-0801 in 147 patients at multiple centers across the US. Oramed is expected to commence the trial after

Once the patent is issued, PROLOR would gain additional intellectual property protection covering methods for the induction of growth in growth hormone deficient patients. PROLOR president Shai Novik

As part of the agreement, Celgene will fund $35m as upfront payment towards research and development of VTX-2337 through pre-defined clinical endpoints. The agreement also provides Celgene with

Almac has acquired the packaging line in view of growing client demand for larger blister sizes, multi unit blister formats along with non permeability and enhanced environmental protection

The risk assessment test, which combines clinical and genetic factors, examines a woman’s clinical risk factors, such as lifetime exposure to estrogen, along with scientifically validated genetic markers

Caffeine Citrate Injection, USP and Caffeine Citrate Oral Solution, USP are indicated for the short-term treatment of apnea of prematurity in infants between 28 and less than 33